415 related articles for article (PubMed ID: 12634359)
41. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
Raux H; Coulon P; Lafay F; Flamand A
Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
[TBL] [Abstract][Full Text] [Related]
42. The C domain in the surface envelope glycoprotein of subgroup C feline leukemia virus is a second receptor-binding domain.
Rey MA; Prasad R; Tailor CS
Virology; 2008 Jan; 370(2):273-84. PubMed ID: 17945326
[TBL] [Abstract][Full Text] [Related]
43. Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.
Chiang CY; Pan YR; Chou LF; Fang CY; Wang SR; Yang CY; Chang HY
Virology; 2007 May; 361(2):364-71. PubMed ID: 17222436
[TBL] [Abstract][Full Text] [Related]
44. Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.
O'Reilly L; Roth MJ
J Virol; 2000 Jan; 74(2):899-913. PubMed ID: 10623753
[TBL] [Abstract][Full Text] [Related]
45. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
[TBL] [Abstract][Full Text] [Related]
46. Pathogenicity of a mutant friend spleen focus-forming virus encoding an Env-like membrane glycoprotein (gp55) with substitution by a xenotropic murine leukemia virus Env gp70 sequence.
Yugawa T; Amanuma H
Microbiol Immunol; 1998; 42(4):335-9. PubMed ID: 9623923
[TBL] [Abstract][Full Text] [Related]
47. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.
Johnston ER; Albritton LM; Radke K
J Virol; 2002 Nov; 76(21):10861-72. PubMed ID: 12368329
[TBL] [Abstract][Full Text] [Related]
48. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.
Glaser AL; de Vries AA; Dubovi EJ
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2223-33. PubMed ID: 7561759
[TBL] [Abstract][Full Text] [Related]
49. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
[TBL] [Abstract][Full Text] [Related]
50. The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system.
Kayman SC; Park H; Saxon M; Pinter A
J Virol; 1999 Mar; 73(3):1802-8. PubMed ID: 9971757
[TBL] [Abstract][Full Text] [Related]
51. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein.
Kubo H; Yamada YK; Taguchi F
J Virol; 1994 Sep; 68(9):5403-10. PubMed ID: 7520090
[TBL] [Abstract][Full Text] [Related]
52. Identification of a novel overlapping sequential E epitope (E') on the bovine leukaemia virus SU glycoprotein and analysis of immunological data.
Forti K; Rizzo G; Cagiola M; Ferrante G; Marini C; Feliziani F; Pezzotti G; De Giuseppe A
Vet Microbiol; 2014 Aug; 172(1-2):157-67. PubMed ID: 24916842
[TBL] [Abstract][Full Text] [Related]
53. Mutational analysis of the putative receptor-binding domain of Moloney murine leukemia virus glycoprotein gp70.
Panda BR; Kingsman SM; Kingsman AJ
Virology; 2000 Jul; 273(1):90-100. PubMed ID: 10891411
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
Alhammad Y; Gu J; Boo I; Harrison D; McCaffrey K; Vietheer PT; Edwards S; Quinn C; Coulibaly F; Poumbourios P; Drummer HE
J Virol; 2015 Dec; 89(24):12245-61. PubMed ID: 26378182
[TBL] [Abstract][Full Text] [Related]
55. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
Oliphant T; Nybakken GE; Engle M; Xu Q; Nelson CA; Sukupolvi-Petty S; Marri A; Lachmi BE; Olshevsky U; Fremont DH; Pierson TC; Diamond MS
J Virol; 2006 Dec; 80(24):12149-59. PubMed ID: 17035317
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes.
Bricker BJ; Snyder RM; Fox JW; Volk WA; Wagner RR
Virology; 1987 Dec; 161(2):533-40. PubMed ID: 2446424
[TBL] [Abstract][Full Text] [Related]
57. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.
Gromowski GD; Barrett ND; Barrett AD
J Virol; 2008 Sep; 82(17):8828-37. PubMed ID: 18562544
[TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.
Lip KM; Shen S; Yang X; Keng CT; Zhang A; Oh HL; Li ZH; Hwang LA; Chou CF; Fielding BC; Tan TH; Mayrhofer J; Falkner FG; Fu J; Lim SG; Hong W; Tan YJ
J Virol; 2006 Jan; 80(2):941-50. PubMed ID: 16378996
[TBL] [Abstract][Full Text] [Related]
59. Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro.
Nihrane A; Fujita K; Willey R; Lyu MS; Silver J
J Virol; 1996 Mar; 70(3):1882-9. PubMed ID: 8627713
[TBL] [Abstract][Full Text] [Related]
60. Subcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: involvement in superinfection interference.
Jobbagy Z; Garfield S; Baptiste L; Eiden MV; Anderson WB
J Virol; 2000 Mar; 74(6):2847-54. PubMed ID: 10684301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
